Product ID |
Product Name |
CAS# |
Purity |
Y3295819 |
2-{[(tert-butoxy)carbonyl]amino}-5-fluoro-4-(fluoromethyl)pentanoic acid |
2803823-60-9 |
95% |
Y3181103 |
benzyl 2-ethyl-4-hydroxy-5H,6H,7H,8H-pyrido[3,4-d]pyrimidine-7-carboxylate |
2839144-48-6 |
95% |
Y3181104 |
3-{2-chloro-5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl}piperidine-2,6-dione |
2883675-03-2 |
95% |
Y3239642 |
ethyl 4-(aminomethyl)-3-oxaspiro[bicyclo[2.1.1]hexane-2,3'-oxetane]-1-carboxylate hydrochloride |
2490400-46-7 |
95% |
Y3249005 |
4-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-3-oxaspiro[bicyclo[2.1.1]hexane-2,3'-oxetane]-1-carboxylic acid |
2490401-41-5 |
95% |
Y3244607 |
4-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-3-oxaspiro[bicyclo[2.1.1]hexane-2,1'-cyclobutane]-1-carboxylic acid |
2490400-54-7 |
95% |
Y3291182 |
2-{[6-({5-chloro-2-[(3R,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-4-yl}amino)-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl]oxy}acetic acid, cis |
2230407-57-3 |
95% |
Y3119790 |
WBC100 |
2095780-08-6 |
95.0% |
Y3119804 |
tert-butyl N-(3-ethenyloxolan-3-yl)carbamate |
2229219-99-0 |
95% |
Y3289695 |
4-(3-bromopropyl)-1,1-difluorocyclohexane |
2228387-58-2 |
95% |
Y3289919 |
[(2-methanesulfonylphenyl)methyl](methyl)amine |
1537500-58-5 |
95% |
Y3119785 |
5-bromo-1-cyclopropyl-1H-pyrazole-4-carboxylic acid |
1896867-76-7 |
95% |
Y3294339 |
(Rac)-Baxdrostat |
1428652-15-6 |
99% |
Y3288566 |
DSPE-Thiol |
144735-82-0 |
90% |
Y3119773 |
(7R)-SBP-0636457 |
1422180-61-7 |
98.36% |
Y3316683 |
1-(2,4-Dichlorophenyl)-2-methyl-1-propanone |
107680-47-7 |
95% |
Y3119792 |
(1R,3S)-Compound E |
504428-17-5 |
95% |
Y3307544 |
(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5,5,5-trifluoropentanoic acid |
144207-42-1 |
95% |
Y3292137 |
D-Fructose-d |
374089-83-5 |
98% |
Y3307998 |
(R)-Vitamin D2 |
116559-84-3 |
97% |
Y3242858 |
(S)-Sabutoclax |
1228178-73-1 |
95% |
Y3287481 |
(S)-GLPG0974 |
2326220-69-1 |
98% |
Y3286840 |
(S,S,S)-AHPC-Boc |
1797406-74-6 |
97% |
Y3297351 |
Canlitinib |
2222730-78-9 |
97% |
Y3286457 |
WAY-608094 |
312590-55-9 |
98% |
Y3314950 |
Anticancer agent 149 |
1810733-76-6 |
95% |
Y3119788 |
(R)-OP-1074 |
1443752-77-9 |
95% |
Y3123115 |
4-Chloro-2-(piperidin-4-yl)phenol |
1176104-24-7 |
95% |
Y3309488 |
N-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-((4-oxo-3,4-dihydroquinazolin-2-yl)thio)acetamide |
675197-89-4 |
98% |
Y3245872 |
MMAF intermediate 1 |
161485-82-1 |
99% |
Y3236040 |
(R)-MK-5046 |
1021736-25-3 |
98.21% |
Y3298086 |
Azido-PEG3-C6-Cl |
1625717-44-3 |
95% |
Y3291210 |
Biotin-PEG4-SH |
2762393-22-4 |
95% |
Y3295060 |
Exatecan Intermediate 4 |
2436720-50-0 |
95% |
Y3297007 |
Diethyl succinate-13C4 |
1628796-56-4 |
95% |
Y3296351 |
GW7604 |
361203-06-7 |
98% |
Y3290472 |
MRL-494 hydrochloride |
2699937-04-5 |
98% |
Y3311999 |
(R)-8-Bromo-2-Boc-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-amine |
2247616-17-5 |
95% |
Y3295844 |
CS640 |
2388506-83-8 |
99% |
Y3297237 |
Atg4B-IN-2 |
2765008-88-4 |
98% |
Y3253088 |
PTC258 |
2476724-74-8 |
98% |
Y3247060 |
(R)-mchm5U |
89665-84-9 |
99.43% |
Y3175475 |
Cy7.5 maleimide |
2270866-73-2 |
97% |
Y3294012 |
WAY-620147 |
515866-67-8 |
98% |
Y3175411 |
IGF-1R inhibitor-2 |
1116236-15-7 |
95% |
Y3297337 |
LMTK3-IN-1 |
2764850-23-7 |
98% |
Y3285793 |
PD-L1-IN-2 |
2894733-91-4 |
98% |
Y3171740 |
CLK1-IN-3 |
2922550-28-3 |
98.03% |
Y3311154 |
Dynamin IN-2 |
1345853-49-7 |
98% |
Y3173446 |
5-PT formic |
2906227-87-8 |
99% |
Y3317523 |
ApoA-I mimetic peptide |
221882-20-8 |
98% |
Y3310575 |
DOTA-LM3 |
1192362-32-5 |
98% |
Y3309023 |
AH1 |
181272-91-3 |
98% |
Y3318745 |
VH 101, acid |
2408341-97-7 |
98% |
Y3181891 |
BZiPAR |
254451-46-2 |
94.00% |
Y3176251 |
HP210 |
728039-52-9 |
98.96% |
Y3307009 |
2-Amino-8-oxononanoic acid hydrochloride |
2984160-77-0 |
98% |
Y3176897 |
PROTAC EGFR degrader 3 |
2768472-28-0 |
97.39% |
Y3176900 |
Tesirine intermediate-2 |
1430738-34-3 |
98% |
Y3178823 |
ART-IN-1 |
2418014-98-7 |
98.91% |
Y3311940 |
BJJF078 |
2531244-56-9 |
98% |
Y3178944 |
Pancreatic lipase/Carboxylesterase 1-IN-1 |
194235-21-7 |
99.26% |
Y3177011 |
SNIPER(TACC3)-11 |
2906151-68-4 |
99.58% |
Y3174700 |
Biotin-PEG-Biotin |
194920-55-3 |
95.0% |
Y3177012 |
Ilaprazole sodium hydrate |
2322264-11-7 |
99.15% |
Y3287318 |
NPBA |
524033-40-7 |
99% |
Y3308453 |
Dinotefuran-d3 |
2934813-27-9 |
95% |
Y3306544 |
AZD-4877 |
758722-49-5 |
99% |
Y3145139 |
Biotin-hexanamide-(L-Thyroxine) |
2278192-78-0 |
98.60% |
Y3144870 |
AR antagonist 3 |
349573-58-6 |
99.96% |
Y3307539 |
AFM32a hydrochloride |
2988594-85-8 |
99% |
Y3289898 |
3-(3-cyano-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-3-yl)propanoic acid |
2580221-56-1 |
95% |
Y3306718 |
Antileishmanial agent-2 |
2863687-18-5 |
95% |
Y3144881 |
NICE-01 |
2982819-94-1 |
99.53% |
Y3144884 |
URAT1&XO inhibitor 2 |
1239488-96-0 |
98.69% |
Y3171507 |
SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 |
1373170-36-5 |
95.08% |
Y3173431 |
Monomethyl auristatin E intermediate-9 |
120205-58-5 |
95% |
Y3171736 |
Cisd2 agonist 2 |
2916371-59-8 |
98.29% |
Y3177397 |
ASN90 |
1884154-02-2 |
99.63% |
Y3181115 |
Thalidomide-NH-C9-NH2 hydrochloride |
2305936-77-8 |
95% |
Y3177398 |
Fmoc-Val-Ala-aminomethyl acetate |
2505045-86-1 |
97.30% |
Y3290095 |
QST4 |
2991427-35-9 |
99% |
Y3175849 |
URAT1 inhibitor 8 |
1632005-33-4 |
98.01% |
Y3181136 |
KAT modulator-1 |
1314006-43-3 |
98.0% |
Y3179061 |
FTX-6746 |
2829349-96-2 |
98.68% |
Y3291123 |
Bio-AMS |
1393881-52-1 |
98% |
Y3311033 |
HDAC-IN-52 |
2075787-77-6 |
98% |
Y3179323 |
CUR5g |
1370032-20-4 |
98.69% |
Y3311570 |
PRMT5:MEP50 PPI |
3031536-71-4 |
98% |
Y3176252 |
LSD1-IN-24 |
4734-59-2 |
99% |
Y3171273 |
USP7-IN-11 |
2763872-32-6 |
99% |
Y3305669 |
XL01126 |
3011029-58-3 |
99% |
Y3298035 |
3-bromo-1-methyl-1H-pyrazole-5-sulfonyl fluoride |
2229255-81-4 |
95% |
Y3290244 |
1,4-Ditosyl-1,4-diazepan-6-one |
203722-04-7 |
95% |
Y3291766 |
Ethyl 3-(4-fluoropyridin-2-yl)prop-2-enoate |
1799442-81-1 |
95% |
Y3294767 |
4-[1-Methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]benzoic acid |
2821751-71-5 |
95% |
Y3294741 |
1-(3,4-difluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ol |
1082528-72-0 |
95% |
Y3290828 |
1,2,3,7,8,9,10-heptahydrocyclohepta[b]-quinoline-4,6-dione |
2273835-28-0 |
95% |
Y3293107 |
3-Furancarboxylic acid, 5-(3,4-dimethoxyphenyl)-2-methyl-, methyl ester |
1334598-61-6 |
95% |
Y3286676 |
3-{4-[(tert-butoxy)carbonyl]-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperazin-2-yl}benzoic acid |
2913406-46-7 |
95% |